BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35131873)

  • 21. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.
    Yuzugullu H; Benhaj K; Ozturk N; Senturk S; Celik E; Toylu A; Tasdemir N; Yilmaz M; Erdal E; Akcali KC; Atabey N; Ozturk M
    Mol Cancer; 2009 Oct; 8():90. PubMed ID: 19849855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetics and targeted therapy of WNT-related human diseases (Review).
    Katoh M; Katoh M
    Int J Mol Med; 2017 Sep; 40(3):587-606. PubMed ID: 28731148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling.
    Chen F; Chen X; Ren Y; Weng G; Keng PC; Chen Y; Lee SO
    J Mol Med (Berl); 2019 Aug; 97(8):1169-1182. PubMed ID: 31187175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.
    Schweizer L; Rizzo CA; Spires TE; Platero JS; Wu Q; Lin TA; Gottardis MM; Attar RM
    BMC Cell Biol; 2008 Jan; 9():4. PubMed ID: 18218096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.
    Rajan P; Sudbery IM; Villasevil ME; Mui E; Fleming J; Davis M; Ahmad I; Edwards J; Sansom OJ; Sims D; Ponting CP; Heger A; McMenemin RM; Pedley ID; Leung HY
    Eur Urol; 2014 Jul; 66(1):32-9. PubMed ID: 24054872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt/β-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell, SKOV-3.
    Basu M; Roy SS
    J Biol Chem; 2013 Feb; 288(6):4355-67. PubMed ID: 23250740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ROR1 and ROR2 expression in pancreatic cancer.
    Liu D; Sharbeen G; Phillips P; ; Ford CE
    BMC Cancer; 2021 Nov; 21(1):1199. PubMed ID: 34763666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway.
    Li Q; Ye L; Guo W; Wang M; Huang S; Peng X
    J Exp Clin Cancer Res; 2017 Jun; 36(1):85. PubMed ID: 28645312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context.
    Mikels AJ; Nusse R
    PLoS Biol; 2006 Apr; 4(4):e115. PubMed ID: 16602827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein kinase A activation enhances β-catenin transcriptional activity through nuclear localization to PML bodies.
    Zhang M; Mahoney E; Zuo T; Manchanda PK; Davuluri RV; Kirschner LS
    PLoS One; 2014; 9(10):e109523. PubMed ID: 25299576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.
    Bleckmann A; Conradi LC; Menck K; Schmick NA; Schubert A; Rietkötter E; Arackal J; Middel P; Schambony A; Liersch T; Homayounfar K; Beißbarth T; Klemm F; Binder C; Pukrop T
    Clin Exp Metastasis; 2016 Apr; 33(4):309-23. PubMed ID: 26862065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SOX30, a target gene of miR-653-5p, represses the proliferation and invasion of prostate cancer cells through inhibition of Wnt/β-catenin signaling.
    Fu Q; Sun Z; Yang F; Mao T; Gao Y; Wang H
    Cell Mol Biol Lett; 2019; 24():71. PubMed ID: 31889959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noncanonical Wnt Signaling Promotes Myofibroblast Differentiation in Pulmonary Fibrosis.
    Liu T; Gonzalez De Los Santos F; Hirsch M; Wu Z; Phan SH
    Am J Respir Cell Mol Biol; 2021 Nov; 65(5):489-499. PubMed ID: 34107237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors.
    Grumolato L; Liu G; Mong P; Mudbhary R; Biswas R; Arroyave R; Vijayakumar S; Economides AN; Aaronson SA
    Genes Dev; 2010 Nov; 24(22):2517-30. PubMed ID: 21078818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt5a mediated canonical Wnt signaling pathway activation in orthodontic tooth movement: possible role in the tension force-induced bone formation.
    Fu HD; Wang BK; Wan ZQ; Lin H; Chang ML; Han GL
    J Mol Histol; 2016 Oct; 47(5):455-66. PubMed ID: 27456852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noncanonical Wnt5a enhances Wnt/β-catenin signaling during osteoblastogenesis.
    Okamoto M; Udagawa N; Uehara S; Maeda K; Yamashita T; Nakamichi Y; Kato H; Saito N; Minami Y; Takahashi N; Kobayashi Y
    Sci Rep; 2014 Mar; 4():4493. PubMed ID: 24670389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer.
    Rasmussen NR; Wright TM; Brooks SA; Hacker KE; Debebe Z; Sendor AB; Walker MP; Major MB; Green J; Wahl GM; Rathmell WK
    J Biol Chem; 2013 Sep; 288(36):26301-26310. PubMed ID: 23893409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
    Maeda K; Kobayashi Y; Udagawa N; Uehara S; Ishihara A; Mizoguchi T; Kikuchi Y; Takada I; Kato S; Kani S; Nishita M; Marumo K; Martin TJ; Minami Y; Takahashi N
    Nat Med; 2012 Feb; 18(3):405-12. PubMed ID: 22344299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interplay Between SOX9, Wnt/β-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer.
    Khurana N; Sikka SC
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31027362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Wnt/β-catenin pathway overcomes therapeutic resistance to abiraterone in castration-resistant prostate cancer.
    Atawia IM; Kushwaha PP; Verma S; Lin S; Shankar E; Abdel-Gawad O; Gupta S
    Mol Carcinog; 2023 Sep; 62(9):1312-1324. PubMed ID: 37232341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.